Immunomodulatory actions of lysophosphatidylcholine

Biomolecules and Therapeutics

Volumn 16, Issue 2, 2008, Pages 69-76

  Hong, Chang Won ^a   Song, Dong Keun ^a  

^a Hallym University   (South Korea)

Author keywords

Lymphocyte; Lysophosphatidylcholine; Macrophage; Monocyte; Neutrophil

Indexed keywords

CALCIUM; CD40 LIGAND; GAMMA INTERFERON; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; IMMUNOMODULATING AGENT; INTERLEUKIN 1BETA; LYSOPHOSPHATIDYLCHOLINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE D; PROTEIN KINASE ZAP 70; PROTEIN P56; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CALCIUM TRANSPORT; CHEMOTAXIS; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PROTEIN PHOSPHORYLATION; REVIEW; SEPSIS;

EID: 68449093696     PISSN: 19769148     EISSN: None     Source Type: Journal    
DOI: 10.4062/biomolther.2008.16.2.069     Document Type: Review

References (66)

1. Asaoka, Y., Oka, M., Yoshida, K. and Nishizuka, Y. (1991). Lysophosphatidylcholine as a possible second messenger synergistic to diacylglycerol and calcium ion for T-lymphocyte activation. Biochem Biophys Res Commun. 178(3), 1378-1385.
2. Asaoka, Y., Oka, M., Yoshida, K., Sasaki, Y. and Nishizuka, Y. (1992). Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase C. Proc Natl Acad Sci USA. 89(14), 6447-6451.
3. Bauldry, S. A. and Wooten, R. E. (1997). Induction of cytosolic phospholipase A2 activity by phosphatidic acid and diglycerides in permeabilized human neutrophils: interrelationship between phospholipases D and A2. Biochem J. 322 (Pt 2), 353-363.
4. Biffl, W. L., Carnaggio, R., Moore, E. E., Ciesla, D. J., Johnson, J. L. and Silliman, C. C. (2003). Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation. Surgery. 134(1), 86-91. (Pubitemid 36904485)
5. Chen, G., Li, J., Qiang, X., Czura, C. J., Ochani, M., Ochani, K., Ulloa, L., Yang, H., Tracey, K. J., Wang, P., Sama, A. E. and Wang, H. (2005). Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res. 46(4), 623-627. (Pubitemid 43073271)
6. Coutant, F., Agaugué, S., Perrin-Cocon, L., André, P. and Lotteau, V. (2004). Sensing environmental lipids by dendritic cell modulates its function. J Immunol. 172(1), 54-60. (Pubitemid 38020455)
7. Coutant, F., Perrin-Cocon, L., Agaugué, S., Delair, T., André, P. and Lotteau, V. (2002). Mature dendritic cell generation promoted by lysophosphatidylcholine. J Immunol. 169(4), 1688-1695. (Pubitemid 34857626)
8. De Vries, H. E., Ronken, E., Reinders, J. H., Buchner, B., Van Berkel, T. J. and Kuiper, J. (1998). Acute effects of oxidized low density lipoprotein on metabolic responses in macrophages. FASEB J. 12(1), 111-118. (Pubitemid 28060276)
9. Drobnik, W., Liebisch, G., Audebert, F. X., Frohlich, D., Gluck, T., Vogel, P., Rothe, G. and Schmitz, G. (2003). Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res. 44(4), 754-761. (Pubitemid 37279677)
10. Engelmann, B., Zieseniss, S., Brand, K., Page, S., Lentschat, A., Ulmer, A. J. and Gerlach, E. (1999). Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine. Arterioscler Thromb Vasc Biol. 19(1), 47-53. (Pubitemid 29031911)
11. Englberger, W., Bitter-Suermann, D. and Hadding, U. (1987). Influence of lysophospholipids and PAF on the oxidative burst of PMNL. Int J Immunopharmacol. 9(3), 275-282. (Pubitemid 17080238)
12. Frasch, S. C., Zemski-Berry, K., Murphy, R. C., Borregaard, N., Henson, P. M. and Bratton, D. L. (2007). Lysophospholipids of different classes mobilize neutrophil secretory vesicles and induce redundant signaling through G2A. J Immunol. 178(10), 6540-6548. (Pubitemid 46717437)
13. Ginsburg, I., Ward, P. A. and Varani, J. (1989). Lysophosphatides enhance superoxide responses of stimulated human neutrophils. Inflammation. 13(2), 163-174. (Pubitemid 19148052)
14. Gómez-Muñoz, A., O'Brien, L., Hundal, R. and Steinbrecher, U. P. (1999). Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages. J Lipid Res. 40(6), 988-993. (Pubitemid 29287869)
15. Han, K. H., Hong, K. H., Ko, J., Rhee, K. S., Hong, M. K., Kim, J. J., Kim, Y. H. and Park, S. J. (2004). Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells. Journal of Leukocyte Biology. 76(1), 195-202. (Pubitemid 38857187)
16. Huang, Y. H., Schafer-Elinder, L., Wu, R., Claesson, H. E. and Frostegard, J. (1999). Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. Clin Exp Immunol. 116(2), 326-331. (Pubitemid 29219732)
17. Jackson, S. K., Abate, W., Parton, J., Jones, S. and Harwood, J. L. (2008). Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response. Journal of Leukocyte Biology. (Pubitemid 351960283)
18. Jing, Q., Xin, S. M., Zhang, W. B., Wang, P., Qin, Y. W. and Pei, G. (2000). Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ Res. 87(1), 52-59. (Pubitemid 30456935)
19. Kishimoto, T., Soda, Y., Matsuyama, Y. and Mizuno, K. (2002). An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. Clin Biochem. 35(5), 411-416. (Pubitemid 35247952)
20. Lauber, K., Bohn, E., Krober, S. M., Xiao, Y. J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., Xu, Y., Autenrieth, I. B., Schulze-Osthoff, K., Belka, C., Stuhler, G. and Wesselborg, S. (2003). Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 113(6), 717-730. (Pubitemid 36724936)
21. Lee, H. Y., Kang, H. K., Yoon, H. R., Kwak, J. Y. and Bae, Y. S. (2004). Lysophosphatidic acid is a mediator of Trp-Lys-Tyr-Met-Val-d-Met-induced calcium influx. Biochem Biophys Res Commun. 324(1), 458-465. (Pubitemid 39311517)
22. Lee, Y. K., Im, Y. J., Kim, Y. L. and Im, D. S. (2006). Characterization of Ca2+ influx induced by dimethylphytosphingosine and lysophosphatidylcholine in U937 monocytes. Biochem Biophys Res Commun. 348(3), 1116-1122.
23. Legradi, A., Chitu, V., Szukacsov, V., Fajka-Boja, R., Szekely Szucs, K. and Monostori, E. (2004). Lysophosphatidylcholine is a regulator of tyrosine kinase activity and intracellular Ca(2+) level in Jurkat T cell line. Immunol Lett. 91(1), 17-21. (Pubitemid 38147741)
24. Lin, P., Welch, E. J., Gao, X. P., Malik, A. B. and Ye, R. D. (2005). Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J Immunol. 174(5), 2981-2989. (Pubitemid 40279718)
25. Liu-Wu, Y., Hurt-Camejo, E. and Wiklund, O. (1998). Lysophosphatidylcholine induces the production of IL-1β by human monocytes. Atherosclerosis. 137(2), 351-357. (Pubitemid 28215881)
26. McMurray, H. F., Parthasarathy, S. and Steinberg, D. (1993). Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest. 92(2), 1004-1008. (Pubitemid 23262425)
27. Müller, J., Petkovi, M., Schiller, J., Arnold, K., Reichl, S. and Arnhold, J. (2002). Effects of lysophospholipids on the genera tion of reactive oxygen species by fMLP- and PMA-stimulated human neutrophils. Luminescence : the journal of biological and chemical luminescence. 17(3), 141-149. (Pubitemid 135692504)
28. Murch, O., Collin, M., Sepodes, B., Foster, S. J., Mota-Filipe, H. and Thiemermann, C. (2006). Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of gram-negative and gram-positive shock. Br J Pharmacol. 148(6), 769-777. (Pubitemid 44079406)
29. Nakano, T., Raines, E. W., Abraham, J. A., Klagsbrun, M. and Ross, R. (1994). Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA. 91(3), 1069-1073. (Pubitemid 24048510)
30. Ngwenya, B. Z. and Yamamoto, N. (1985). Activation of peritoneal macrophages by lysophosphatidylcholine. Biochim Biophys Acta. 839(1), 9-15.
31. Nishi, E., Kume, N., Ochi, H., Moriwaki, H., Wakatsuki, Y., Higashiyama, S., Taniguchi, N. and Kita, T. (1997). Lysophosphatidylcholine increases expression of heparin-binding epidermal growth factor-like growth factor in human T lymphocytes. Circ Res. 80(5), 638-644. (Pubitemid 27181346)
32. Nishi, E., Kume, N., Ueno, Y., Ochi, H., Moriwaki, H. and Kita, T. (1998). Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes. Circ Res. 83(5), 508-515. (Pubitemid 28411052)
33. Nishioka, H., Horiuchi, H., Arai, H. and Kita, T. (1998). Lysophosphatidylcholine generates superoxide anions through activation of phosphatidylinositol 3-kinase in human neutrophils. FEBS Lett. 441(1), 63-66. (Pubitemid 29012373)
34. Oestvang, J., Anthonsen, M. W. and Johansen, B. (2003). Role of secretory and cytosolic phospholipase A(2) enzymes in lysophosphatidylcholine-stimulated monocyte arachidonic acid release. FEBS Lett. 555(2), 257-262. (Pubitemid 37492880)
35. Ogita, T., Tanaka, Y., Nakaoka, T., Matsuoka, R., Kira, Y., Nakamura, M., Shimizu, T. and Fujita, T. (1997). Lysophosphatidylcholine transduces Ca2+ signaling via the platelet-activating factor receptor in macrophages. Am J Physiol. 272(1 Pt 2), H17-24. (Pubitemid 27066659)
36. Okajima, F., Sato, K., Tomura, H., Kuwabara, A., Nochi, H., Tamoto, K., Kondo, Y., Tokumitsu, Y. and Ui, M. (1998). Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells. Biochem J. 336 (Pt 2), 491-500. (Pubitemid 28564408)
37. Olofsson, K. E., Andersson, L., Nilsson, J. and Björkbacka, H. (2008). Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages. Biochem Biophys Res Commun. 370(2), 348-352.
38. Ousman, S. S. and David, S. (2000). Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia. 30(1), 92-104.
39. Parks, B. W., Gambill, G. P., Lusis, A. J. and Kabarowski, J. H. (2005). Loss of G2A promotes macrophage accumulation in atherosclerotic lesions of low density lipoprotein receptor-deficient mice. J Lipid Res. 46(7), 1405-1415.
40. Perrin-Cocon, L., Agaugue, S., Coutant, F., Saint-Mezard, P., Guironnet-Paquet, A., Nicolas, J. F., Andre, P. and Lotteau, V. (2006). Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses. Vaccine. 24(9), 1254-1263. (Pubitemid 43222032)
41. Peter, C., Waibel, M., Radu, C. G., Yang, L. V., Witte, O. N., Schulze-Osthoff, K., Wesselborg, S. and Lauber, K. (2008). Migration to apoptotic "find-me" signals is mediated via the phagocyte receptor G2A. J Biol Chem. 283(9), 5296-5305.
42. Quinn, M. T., Parthasarathy, S. and Steinberg, D. (1988). Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 85(8), 2805-2809. (Pubitemid 18111684)
43. Radu, C. G., Yang, L. V., Riedinger, M., Au, M. and Witte, O. N. (2004). T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc Natl Acad Sci U S A. 101(1), 245-250. (Pubitemid 38084235)
44. Rikitake, Y., Hirata, K., Yamashita, T., Iwai, K., Kobayashi, S., Itoh, H., Ozaki, M., Ejiri, J., Shiomi, M., Inoue, N., Kawashima, S. and Yokoyama, M. (2002). Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 22(12), 2049-2053. (Pubitemid 36025213)
45. Ryborg, A. K., Deleuran, B., Sogaard, H. and Kragballe, K. (2000). Intracutaneous injection of lysophosphatidylcholine induces skin inflammation and accumulation of leukocytes. Acta Derm Venereol. 80(4), 242-246. (Pubitemid 30743460)
46. Ryborg, A. K., Deleuran, B., Thestrup-Pedersen, K. and Kragballe, K. (1994). Lysophosphatidylcholine: a chemoattractant to human T lymphocytes. Arch Dermatol Res. 286(8), 462-465.
47. Sakai, M., Miyazaki, A., Hakamata, H., Sasaki, T., Yui, S., Yamazaki, M., Shichiri, M. and Horiuchi, S. (1994). Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem. 269(50), 31430-31435. (Pubitemid 24379497)
48. Sakata-Kaneko, S., Wakatsuki, Y., Usui, T., Matsunaga, Y., Itoh, T., Nishi, E., Kume, N. and Kita, T. (1998). Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD4+ T cells. FEBS Lett. 433(1-2), 161-165. (Pubitemid 28386750)
49. Schilling, T., Lehmann, F., Rückert, B. and Eder, C. (2004). Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia. J Physiol (Lond). 557(Pt 1), 105-120. (Pubitemid 38771640)
50. Schmid, B., Finnen, M. J., Harwood, J. L. and Jackson, S. K. (2003). Acylation of lysophosphatidylcholine plays a key role in the response of monocytes to lipopolysaccharide. Eur J Biochem. 270(13), 2782-2788. (Pubitemid 36801818)
51. Silliman, C. C., Clay, K. L., Thurman, G. W., Johnson, C. A. and Ambruso, D. R. (1994). Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med. 124(5), 684-694.
52. Silliman, C. C., Dickey, W. O., Paterson, A. J., Thurman, G. W., Clay, K. L., Johnson, C. A. and Ambruso, D. R. (1996). Analysis of the priming activity of lipids generated during routine storage of platelet concentrates. Transfusion. 36(2), 133-139.
53. Silliman, C. C., Elzi, D. J., Ambruso, D. R., Musters, R. J., Hamiel, C., Harbeck, R. J., Paterson, A. J., Bjornsen, A. J., Wyman, T. H., Kelher, M., England, K. M., McLaughlin-Malaxecheberria, N., Barnett, C. C., Aiboshi, J. and Bannerjee, A. (2003). Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol. 73(4), 511-524. (Pubitemid 38040097)
54. Taylor, L. A., Arends, J., Hodina, A. K., Unger, C. and Massing, U. (2007). Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status. Lipids in health and disease. 6, 17. (Pubitemid 47228412)
55. Weber, C., Erl, W. and Weber, P. C. (1995). Enhancement of monocyte adhesion to endothelial cells by oxidatively modified low-density lipoprotein is mediated by activation of CD11b. Biochem Biophys Res Commun. 206(2), 621-628.
56. Weng, Z., Fluckiger, A. C., Nisitani, S., Wahl, M. I., Le, L. Q., Hunter, C. A., Fernal, A. A., Le Beau, M. M. and Witte, O. N. (1998). A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M. Proc Natl Acad Sci U S A. 95(21), 12334-12339. (Pubitemid 28483766)
57. Wilson-Ashworth, H. A., Judd, A. M., Law, R. M., Freestone, B. D., Taylor, S., Mizukawa, M. K., Cromar, K. R., Sudweeks, S. and Bell, J. D. (2004). Formation of transient non-protein calcium pores by lysophospholipids in S49 Lymphoma cells. J Membr Biol. 200(1), 25-33. (Pubitemid 39180535)
58. Wyman, T. H., Bjornsen, A. J., Elzi, D. J., Smith, C. W., England, K. M., Kelher, M. and Silliman, C. C. (2002). A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: requirements for adherence and chemokine release. Am J Physiol Cell Physiol. 283(6), C1592-1603. (Pubitemid 35340590)
59. Yamamoto, M., Hara, H. and Adachi, T. (2002). The expression of extracellular-superoxide dismutase is increased by lysophosphatidylcholine in human monocytic U937 cells. Atherosclerosis. 163(2), 223-228. (Pubitemid 34615812)
60. Yamamoto, N. and Naraparaju, V. R. (1996). Role of vitamin D3- binding protein in activation of mouse macrophages. J Immunol. 157(4), 1744-1749. (Pubitemid 126449119)
61. Yan, J. J., Jung, J. S., Lee, J. E., Lee, J., Huh, S. O., Kim, H. S., Jung, K. C., Cho, J. Y., Nam, J. S., Suh, H. W., Kim, Y. H. and Song, D. K. (2004). Therapeutic effects of lysophosphatidylcholine in experimental sepsis. Nat Med. 10(2), 161-167. (Pubitemid 38524886)
62. Yang, L. V., Radu, C. G., Wang, L., Riedinger, M. and Witte, O. N. (2005). Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood. 105(3), 1127-1134. (Pubitemid 40170885)
63. Yuan, Y., Schoenwaelder, S. M., Salem, H. H. and Jackson, S. P. (1996). The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase. J Biol Chem. 271(43), 27090-27098. (Pubitemid 26359129)
64. Yun, M. R., Okajima, F. and Im, D. S. (2004). The action mode of lysophosphatidylcholine in human monocytes. J Pharmacol Sci. 94(1), 45-50. (Pubitemid 38197184)
65. Zhu, X., Learoyd, J., Butt, S., Zhu, L., Usatyuk, P. V., Natarajan, V., Munoz, N. M. and Leff, A. R. (2007). Regulation of eosinophil adhesion by lysophosphatidylcholine via a non-store-operated Ca2+ channel. Am J Respir Cell Mol Biol. 36(5), 585-593. (Pubitemid 46676717)
66. Zurgil, N., Afrimzon, E., Shafran, Y., Shovman, O., Gilburd, B., Brikman, H., Shoenfeld, Y. and Deutsch, M. (2007). Lymphocyte resistance to lysophosphatidylcholine mediated apoptosis in atherosclerosis. Atherosclerosis. 190(1), 73-83. (Pubitemid 44920231)